A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells

Yiming Zhang, Yiqiang Huang, Zhong Jin, Xiezhao Li, Bingkun Li, Peng Xu, Peng Huang, Chunxiao Liu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Stem-like prostate cancer (PrCa) cells, also called PrCa stem cells (PrCSCs) or PrCa tumor-initiating cells (PrTICs), are considered to be involved in the mediation of tumor metastasis and may be responsible for the poor prognosis of PrCa patients. Currently, the methods for PrTIC sorting are mainly based on cell surface marker or side population (SP). However, the rarity of these sorted cells limits the investigation of the molecular mechanisms and therapeutic strategies targeting PrTICs. For PrTIC enrichment, we induced cancer stem cell (CSC) properties in PrCa cells by transducing three defined factors (OCT3/4, SOX2, and KLF4), followed by culture with conventional serum-containing medium. The CSC properties in the transduced cells were evaluated by proliferation, cell cycle, SP assay, drug sensitivity technology, in vivo tumorigenicity, and molecular marker analysis of PrCSCs compared with parental cells and spheroids. After culture with serum-containing medium for 8 days, the PrCa cells transduced with the three factors showed significantly enhanced CSC properties in terms of marker gene expression, sphere formation, chemoresistance to docetaxel, and tumorigenicity. The percentage of CD133+/CD44+ cells was ninefold higher in the transduced cell population than in the adherent PC3 cell population (2.25 ± 0.62 vs. 0.25 ± 0.12 %, respectively), and the SP increased to 1.22 ± 0.18 % in the transduced cell population, but was undetectable in the adherent population. This method can be used to obtain abundant PrTIC material and enables a complete understanding of PrTIC biology and development of novel therapeutic agents targeting PrTICs.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalTumor Biology
DOIs
Publication statusAccepted/In press - Apr 25 2016
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Prostatic Neoplasms
Population
docetaxel
Serum
Cell Biology
Cell Cycle
Stem Cells
Neoplasm Metastasis
Technology
Gene Expression

Keywords

  • Enrichment
  • Prostate cancer
  • Reprogramming
  • Tumor-initiating cells

ASJC Scopus subject areas

  • Cancer Research

Cite this

A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells. / Zhang, Yiming; Huang, Yiqiang; Jin, Zhong; Li, Xiezhao; Li, Bingkun; Xu, Peng; Huang, Peng; Liu, Chunxiao.

In: Tumor Biology, 25.04.2016, p. 1-9.

Research output: Contribution to journalArticle

Zhang, Yiming ; Huang, Yiqiang ; Jin, Zhong ; Li, Xiezhao ; Li, Bingkun ; Xu, Peng ; Huang, Peng ; Liu, Chunxiao. / A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells. In: Tumor Biology. 2016 ; pp. 1-9.
@article{10edefd91c484976ad82b0b401163281,
title = "A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells",
abstract = "Stem-like prostate cancer (PrCa) cells, also called PrCa stem cells (PrCSCs) or PrCa tumor-initiating cells (PrTICs), are considered to be involved in the mediation of tumor metastasis and may be responsible for the poor prognosis of PrCa patients. Currently, the methods for PrTIC sorting are mainly based on cell surface marker or side population (SP). However, the rarity of these sorted cells limits the investigation of the molecular mechanisms and therapeutic strategies targeting PrTICs. For PrTIC enrichment, we induced cancer stem cell (CSC) properties in PrCa cells by transducing three defined factors (OCT3/4, SOX2, and KLF4), followed by culture with conventional serum-containing medium. The CSC properties in the transduced cells were evaluated by proliferation, cell cycle, SP assay, drug sensitivity technology, in vivo tumorigenicity, and molecular marker analysis of PrCSCs compared with parental cells and spheroids. After culture with serum-containing medium for 8 days, the PrCa cells transduced with the three factors showed significantly enhanced CSC properties in terms of marker gene expression, sphere formation, chemoresistance to docetaxel, and tumorigenicity. The percentage of CD133+/CD44+ cells was ninefold higher in the transduced cell population than in the adherent PC3 cell population (2.25 ± 0.62 vs. 0.25 ± 0.12 {\%}, respectively), and the SP increased to 1.22 ± 0.18 {\%} in the transduced cell population, but was undetectable in the adherent population. This method can be used to obtain abundant PrTIC material and enables a complete understanding of PrTIC biology and development of novel therapeutic agents targeting PrTICs.",
keywords = "Enrichment, Prostate cancer, Reprogramming, Tumor-initiating cells",
author = "Yiming Zhang and Yiqiang Huang and Zhong Jin and Xiezhao Li and Bingkun Li and Peng Xu and Peng Huang and Chunxiao Liu",
year = "2016",
month = "4",
day = "25",
doi = "10.1007/s13277-016-5046-6",
language = "English",
pages = "1--9",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells

AU - Zhang, Yiming

AU - Huang, Yiqiang

AU - Jin, Zhong

AU - Li, Xiezhao

AU - Li, Bingkun

AU - Xu, Peng

AU - Huang, Peng

AU - Liu, Chunxiao

PY - 2016/4/25

Y1 - 2016/4/25

N2 - Stem-like prostate cancer (PrCa) cells, also called PrCa stem cells (PrCSCs) or PrCa tumor-initiating cells (PrTICs), are considered to be involved in the mediation of tumor metastasis and may be responsible for the poor prognosis of PrCa patients. Currently, the methods for PrTIC sorting are mainly based on cell surface marker or side population (SP). However, the rarity of these sorted cells limits the investigation of the molecular mechanisms and therapeutic strategies targeting PrTICs. For PrTIC enrichment, we induced cancer stem cell (CSC) properties in PrCa cells by transducing three defined factors (OCT3/4, SOX2, and KLF4), followed by culture with conventional serum-containing medium. The CSC properties in the transduced cells were evaluated by proliferation, cell cycle, SP assay, drug sensitivity technology, in vivo tumorigenicity, and molecular marker analysis of PrCSCs compared with parental cells and spheroids. After culture with serum-containing medium for 8 days, the PrCa cells transduced with the three factors showed significantly enhanced CSC properties in terms of marker gene expression, sphere formation, chemoresistance to docetaxel, and tumorigenicity. The percentage of CD133+/CD44+ cells was ninefold higher in the transduced cell population than in the adherent PC3 cell population (2.25 ± 0.62 vs. 0.25 ± 0.12 %, respectively), and the SP increased to 1.22 ± 0.18 % in the transduced cell population, but was undetectable in the adherent population. This method can be used to obtain abundant PrTIC material and enables a complete understanding of PrTIC biology and development of novel therapeutic agents targeting PrTICs.

AB - Stem-like prostate cancer (PrCa) cells, also called PrCa stem cells (PrCSCs) or PrCa tumor-initiating cells (PrTICs), are considered to be involved in the mediation of tumor metastasis and may be responsible for the poor prognosis of PrCa patients. Currently, the methods for PrTIC sorting are mainly based on cell surface marker or side population (SP). However, the rarity of these sorted cells limits the investigation of the molecular mechanisms and therapeutic strategies targeting PrTICs. For PrTIC enrichment, we induced cancer stem cell (CSC) properties in PrCa cells by transducing three defined factors (OCT3/4, SOX2, and KLF4), followed by culture with conventional serum-containing medium. The CSC properties in the transduced cells were evaluated by proliferation, cell cycle, SP assay, drug sensitivity technology, in vivo tumorigenicity, and molecular marker analysis of PrCSCs compared with parental cells and spheroids. After culture with serum-containing medium for 8 days, the PrCa cells transduced with the three factors showed significantly enhanced CSC properties in terms of marker gene expression, sphere formation, chemoresistance to docetaxel, and tumorigenicity. The percentage of CD133+/CD44+ cells was ninefold higher in the transduced cell population than in the adherent PC3 cell population (2.25 ± 0.62 vs. 0.25 ± 0.12 %, respectively), and the SP increased to 1.22 ± 0.18 % in the transduced cell population, but was undetectable in the adherent population. This method can be used to obtain abundant PrTIC material and enables a complete understanding of PrTIC biology and development of novel therapeutic agents targeting PrTICs.

KW - Enrichment

KW - Prostate cancer

KW - Reprogramming

KW - Tumor-initiating cells

UR - http://www.scopus.com/inward/record.url?scp=84964452840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964452840&partnerID=8YFLogxK

U2 - 10.1007/s13277-016-5046-6

DO - 10.1007/s13277-016-5046-6

M3 - Article

C2 - 27113741

AN - SCOPUS:84964452840

SP - 1

EP - 9

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

ER -